Zenabis Provides Operations Update and Highlights for October 2019
Ryan Allway
December 5th, 2019
News
VANCOUVER, Dec. 4, 2019 /CNW/ – Zenabis Global Inc. (TSX:ZENA) (“Zenabis” or the “Company“) is pleased to provide an update on its recent facility construction and licensing activities and recent cannabis production results.
Highlights:
- Cultivation output in October 2019 increased 71% over September yield, totaling 3,586 kg of dried cannabis. This was slightly lower than Zenabis’ August revised forecast output of 3,758 kg.
- Production at Zenabis Atholville underperformed its revised design capacity by 0.4% (the Performance Ratio1).
- Zenabis continues to focus on the completion of construction and licensing of Zenabis Langley. Zenabis’ total annual cultivation design capacity is expected to increase to 143,200 kg of dried cannabis on full completion of construction of Zenabis Langley. Zenabis is awaiting Health Canada approval of the Part 2A license amendment, which will increase Zenabis’ licensed annual production capacity by 69% (from 57,000 kg to 96,400 kg). Zenabis expects to submit the license amendment for Part 2B at Zenabis Langley (additional 14,800 kg of design capacity) as soon as possible following the receipt of the Part 2A amendment.
Andrew Grieve, Chief Executive Officer of Zenabis, stated, “October was another month of strong cannabis cultivation at Zenabis Atholville. With 22 harvests in the month of October, the facility is now essentially at steady-state operations from a cultivation standpoint. The 3,586 kg of dried cannabis yield is roughly in line with our revised forecast. Given 14 of 22 harvests in the month were the first harvests in rooms that were licensed in Q2 and Q3 2019, we are pleased with this outcome. In October, we also solved our previously noted packaging challenges, so packaging is no longer a bottleneck to providing product to our Provincial partners. At the same time, we continue to make significant progress on the construction of Zenabis Langley.”
|
________________________________ |
|
|
1 |
To better reflect the actual performance of its facilities, the Company reports a Performance Ratio, calculated as follows: after each harvest, Zenabis calculates the dry weight cannabis output for each room (the “Total Output”), taking into account the amount of days in production through a combination of: (1) the amount of flower room days used (including turnaround time) for that room; and (2) the amount of flower-room equivalent days required from other flower rooms in support of that harvest (together the “Effective Flower Room Equivalent Days”). Zenabis then divides the Total Output by the Effective Flower Room Equivalent Days in order to produce the “Effective Yield Per Day” for each room, and then divides the Effective Yield Per Day by the Design Capacity Yield Per Day for each room in order to determine actual performance versus the Design Capacity Yield Per Day (this ratio being the “Performance Ratio”). Zenabis believes that the Performance Ratio will provide investors with the best measure of actual cultivation performance versus Zenabis’ published design capacity. Zenabis intends to publish updated design capacities for each of its facilities when a facility has harvested from all its flower rooms (with the update at that time reflecting the most recent performance from each flower room) and again, if required due to significantly different results, when a facility achieves consistent monthly performance at a level that is different from its published Design Capacity. Zenabis revised its Design Capacity at Zenabis Atholville upwards by 35% (equal to Zenabis Atholville’s Performance Ratio for the three months ended June 30, 2019) from 34,300 kg per annum to 46,300 kg per annum. Zenabis no longer reports a Performance Ratio for Zenabis Atholville relative to original design capacity (the kg/day figure used to derive the 34,300 kg design capacity). |
Cannabis Production Summary
In October 2019, Zenabis realized a total harvest weight of 3,586 kg of dried cannabis.
The amount harvested at Zenabis Atholville for the three months ending October 2019 exceeded the revised design capacity of the flower rooms by an average of 13.7%, compared to 25.7% in the three-month period ending September 2019. A month-to-month comparison of actual harvests compared with harvest forecast based on revised design capacity between January 2019 and October 2019 for Zenabis Atholville is provided in the table below.
|
Revised Design Capacity Performance at Zenabis |
Jan 2019 |
Feb |
Mar |
Apr 2019 |
May 2019 |
June 2019 |
July 2019 |
Aug 2019 |
Sept 2019 |
Oct 2019 |
Total |
|
Actual Harvest Weight (kg) |
474 |
480 |
518 |
809 |
908 |
756 |
1,238 |
1,912 |
2,089 |
3,586 |
12,770 |
|
Revised Design Capacity |
467 |
643 |
539 |
796 |
895 |
716 |
1,097 |
1,357 |
1,715 |
3,601 |
11,825 |
|
Difference (kg) |
7 |
(163) |
(21) |
13 |
13 |
40 |
141 |
555 |
374 |
(15) |
944 |
|
Difference (%) – Revised |
1.5% |
(25.3%) |
(3.9%) |
1.6% |
1.5% |
5.6% |
12.9% |
40.9% |
21.8% |
(0.4) % |
8.0% |
|
2 |
The Revised Design Capacity Harvest Weight was derived by converting the actual square footage of flower room space and the forecast canopy for each specific flower room into a kilograms per room per day figure based on Zenabis’ historical yield data at the Zenabis Atholville facility based on the yield performance in the three months ending June 2019 for revised Design Capacity. The Revised Design Capacity Harvest Weight in the table above is the harvest weight that would have resulted if the Design Capacity Yield Per Day for a room was multiplied by the Effective Flower Room Equivalent Days, as defined under “Performance Ratio”. |
In October 2019, Zenabis completed 22 harvests at Zenabis Atholville. The average Performance Ratio for these harvests was 0.4% relative to revised design capacity. In October 2019, Zenabis had no harvests from Zenabis Stellarton or Zenabis Langley.
2019 Harvest Forecast – Zenabis Atholville, Zenabis Stellarton and Zenabis Langley Site A – Part 1
For its existing licensed facilities of Zenabis Atholville, Zenabis Stellarton and Zenabis Langley Site A – Part 1, Zenabis expects to produce approximately 11,6573 kg of dried cannabis from November 2019 through January 2020. Zenabis completed its first harvest from Zenabis Langley at the end of November. Contrary to past forecasts for November that included 1,650 kg from Zenabis Langley (representing achievement of 100% of the current Design Capacity), Zenabis’ updated forecast harvest output from Zenabis Langley for November is approximately 20% of the current Design Capacity of Zenabis Langley. Consistent with past experience, Zenabis remains confident that Zenabis Langley’s Design Capacity will be achieved after ramp-up challenges have been addressed. The following table sets out Zenabis’ estimated aggregate monthly harvests for Zenabis Atholville and Zenabis Stellarton and Zenabis Langley Site A – Part 1 for the remainder of 2019 and January 2020.
|
July 2019 |
Aug 2019 |
Sept 2019 |
Oct 2019 |
Nov 2019 |
Dec 2019 |
Jan 2020 |
Total |
|
|
Forecast (kg)3 |
1,212 |
1,579 |
1,731 |
3,758 |
3,881 |
4,200 |
3,576 |
19,937
|
|
Actual (kg) |
1,238 |
1,996 |
2,089 |
3,586 |
8,825 |
|
3 |
This forward-looking estimate of future harvest results is based on the following material assumptions: (1) Zenabis Stellarton operates at the published design capacity on a room by room basis for the cultivation space that is licensed and in cultivation at the forward-looking periods noted; (2) Zenabis Atholville rooms operate based on the current flower schedule and continue to achieve revised Design Capacity; and (3) the first harvest from Zenabis Langley Site A – Part 1 in November 2019 is 20% of Design Capacity. |
Zenabis intends to provide a monthly cultivation forecast for Zenabis Langley Site A – Part 2A, Zenabis Langley Site A – Part 2B and Zenabis Langley Site A – Part 2C upon receipt of all cultivation license amendments for these phases.
Construction and Facility Update
Zenabis Langley
The first phase of Zenabis Langley (Zenabis Langley Site A – Part 1) is licensed and operational. Zenabis has reached substantial completion on Site A – Part 2A. Zenabis has submitted a cultivation license amendment for Site A – Part 2A and expects to receive Health Canada approval of that amendment in December 2019. Zenabis intends to submit a license amendment for Site A – Part 2B upon the receipt of the Site A – Part 2A license amendment (due to Health Canada regulations, Zenabis cannot submit an amendment while another amendment is outstanding). Zenabis remains focused on converting the remaining phase of Zenabis Langley (Zenabis Langley Site A – Part 2C).
A summary of construction status by phase is provided below:
|
Phase |
Design Capacity |
Description |
|
Part 1 |
9,900 kg |
|
|
Part 2A |
39,400 kg |
|
|
Part 2B |
14,800 kg |
|
|
Part 2C |
32,000 kg |
|
Zenabis Stellarton
In November 2019, Zenabis’ pre-roll production capacity at Zenabis Stellarton reached peak daily output of 40,000 units. As a result, Zenabis has the ability to produce 1.2 million pre-rolls per month (up to 1,200 kg of 1g Re-Up pre-rolls)4. Zenabis has also submitted a sales license application for Zenabis Stellarton and expects to use this site as a fulfilment centre and packaging/processing facility upon receipt of this license.
|
____________________ |
|
|
4 |
Assuming operations for 30 days a month. |
Zenabis Delta
Zenabis is currently in the process of constructing extraction and post-processing capacity, a product development lab, a formulation design lab, and a full ISO certified analytical testing lab at Zenabis Delta. This construction project is expected to be complete in the first half of 2020.
Licensing Update
Zenabis is currently in the process of various licensing applications for Zenabis Delta, Zenabis Langley, Zenabis Stellarton and the Zen Craft Grow program as outlined in the table below:
|
License Submission |
Submission Month |
Annual Design Capacity |
|
Zenabis Delta – Analytical Testing |
May 2019 |
N/A |
|
Zen Craft Grow – Grower 1 |
July 2019 |
350 kg |
|
Zenabis Langley Site A – Part 2A |
September 2019 |
39,400 kg |
|
Zenabis Stellarton – Sales License |
October 2019 |
N/A |
|
Zenabis Langley Site A – Part 2B |
December 20195 |
14,800 kg |
|
Zenabis Langley Site A – Part 2C |
February 20205 |
32,000 kg |
|
5 |
Expected submission timeline subject to receipt of prior license or license amendment for each facility. |
As operations ramp-up in multiple locations resulting in a significantly greater number of harvests per month, more time will be required to consolidate data and release publicly as part of our regular Operational Updates. Consequently, the Company expects to release its Operational Updates for a given month within 6 weeks following the end of such month.
Please view the following link for Zenabis operational update presentation:
https://www.zenabis.com/docs/zenabis-operations.pdf
About Zenabis
Zenabis is a significant Canadian licensed cultivator of medical and recreational cannabis, and a propagator and cultivator of floral and vegetable products. Zenabis employs staff coast-to-coast, across facilities in Atholville, New Brunswick; Delta, Aldergrove, Pitt Meadows and Langley, British Columbia; and Stellarton, Nova Scotia. Zenabis currently has 57,000 kg of licensed cannabis cultivation space across four licensed facilities. Zenabis has 3.5 million square feet of total facility space dedicated to a mix of cannabis production and cultivation and its propagation and floral business.
Zenabis expects its Zenabis Atholville, Zenabis Stellarton and Zenabis Langley facilities to have a licensed annual production capacity of 143,200 kg of dried cannabis by the second quarter of 2020. The Zenabis brand name is used in the cannabis medical market, the Namaste, Blazery, and Re-Up brand names are used in the cannabis adult-use recreational market, and the True Büch brand name is used for Zenabis’ kombucha products.
Forward Looking Information
This news release contains statements that may constitute “forward-looking information” within the meaning of applicable Canadian securities legislation. Forward-looking information may include, among others, statements regarding the future plans, costs, objectives or performance of Zenabis, or the assumptions underlying any of the foregoing. In this news release, words such as “may”, “would”, “could”, “will”, “likely”, “believe”, “expect”, “anticipate”, “intend”, “plan”, “estimate” and similar words and the negative form thereof are used to identify forward-looking statements. In this news release, forward-looking statements relate, among other things, to: the projected kilogram yield of licensed facility space and facility space in the process of, or scheduled for, construction and/or licensing; our expectations for future harvests; the expected timing and completion of current and planned conversion, expansion and optimization of our facilities, including Zenabis Langley; our plans for Zenabis Delta; the expected submissions of license amendment applications and site evidence packages; the licensing of our facilities and projected timing thereof; our expectations for our extraction projects, equipment and capacity; our expectations for processing output; our expectations regarding our packaging equipment; the effect of hemp cultivation on our cannabis cultivation abilities; and the expected content of future operational updates. Forward-looking statements should not be read as guarantees of future performance or results, and will not necessarily be accurate indications of whether, or the times at or by which, such future performance will be achieved. No assurance can be given that any events anticipated by the forward-looking information will transpire or occur. Forward-looking information is based on information available at the time and/or management’s good-faith belief with respect to future events and are subject to known or unknown risks, uncertainties, assumptions and other unpredictable factors, many of which are beyond Zenabis’ control. These risks, uncertainties and assumptions include, but are not limited to, those described in the shelf prospectus dated April 9, 2019, a copy of which is available on SEDAR at www.sedar.com and could cause actual events or results to differ materially from those projected in any forward-looking statements. Furthermore, any forward-looking information with respect to available space for cannabis production is subject to the qualification that management of Zenabis may decide not to use all available space for cannabis production, and the assumptions that any construction or conversion would not be cost prohibitive, required permits will be obtained and the labour, materials and equipment necessary to complete such construction or conversion will be available. Accordingly, readers should not place undue reliance on the forward-looking statements and information contained in this news release. Zenabis does not intend, nor undertake any obligation, to update or revise any forward-looking information contained in this news release to reflect subsequent information, events or circumstances or otherwise, except if required by applicable laws
For more information, visit: https://www.zenabis.com.
SOURCE Zenabis Global Inc.
For further information: Media Relations: Email: media@zenabis.com, Phone: 1-855-936-2247; Investor Relations: E-mail: invest@zenabis.com, Phone: 1-855-936-2247
Related Links
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
About Ryan Allway
Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.
Search CannabisFN
Press Coverage
Psychedelics Index
Top Videos
Matthew Nordgren is an ambitious executive, dedicated philanthropist, and accomplished athlete who brings a unique passion to creating strategic alliances. He has breadth and depth of experience in finance, corporate development, and capital sourcing, as well as in building highly motivated teams of skilled professionals. In 2005, Mr. Nordgren received his education at the University […]
Matt Hawkins is the founder and managing principal of Cresco Capital Partners, LLC (“Cresco”), a private equity firm focused specifically on investing in the legalized cannabis industry. Since its inception in the summer of 2015, Cresco has made 14 investments out of its first fund and is currently raising this fund, Fund II. Prior to the […]
KetamineOne Capital is focused on consolidating medical clinics and becoming a North American leader in mental health treatments.
BDS Analytics aims to drive the cannabis sector to thrive with well-informed decisions based on factual data. By capturing millions of transactions from dispensary point-of-sale systems we provide actionable insights based on accurate information enabling dispensaries, brands, and growers to sustain their success. Their vision is to be your indispensable source for cannabis industry data […]
Network Partners
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer
